Professional Documents
Culture Documents
Αιμοκάθαρση
Αιμοκάθαρση
Αιμοκάθαρση
.: 2107298586
FAX: 2107237705
E-mail: nefreter@otenet.gr
(. 2)
(. 4)
(. 7)
(. 11)
(. 14)
(. 16)
(. 20)
(. 23)
/
1)
)
3 12
/,
.
.
) / (High-flux)
()
.
:
1)
2)
3)
4)
(
)
on-line * .
.
* ON-LINE
1.
2.
3.
4.
5.
6.
7.
8.
(
, ,
).
() ,
( 2 )
.
3
/,
(Equilibrated Kt/V).
3 /,
() Kt/V (std Kt/V),
(SRI) (EKR).
IV)
3 /
eKt/V 1.2.
, eKt/V 1.4,
-.
3 /,
SRI=2.
2)
:
I)
.
.
.
.
20mmHg
10mmHg
/.
.
)
6gr/, (..
),
2 ,
. ,
, .
. ,
.
() (Ultrafiltration profiling)
.
(
)
.
(Sodium profiling),
( 144mmol/l),
,
.
.
1,5mmol/l
, .
0,25mmol/l,
.
35-36C ( )
.
0,5C 36,5C .
35C .
,
.
,
.
,
.
(Minontrine- 1 ) 2,5-10mg 30
,
.
L-
.
V)
1 : ( ),
,
, , 36,5C,
2 :
, ,
36,5C ( 35C)
( : ), ,
,
1,5mmol/l
3 ( ) : , L-
( ).
V)
trendelenburg (
,
).
.
4 trendelenburg
.
.
3)
) :
.
.
, 6
50 .
5 ,
3.
)
:
-
, (BM),
(SGA), , (nPNA),
, (, DEXA, NEAR-INFRAND REACTANCE).
:
) :
.
.
.
,
.
) (BMI) : BMI
> 23
) (Subjective Global Assessement, SGA) : SGA
) :
.
4
fistoula.
) (nPNA):
1g/kg /
) - :
40g/l, .
. -
0,3g/l.
) :
.
) ( ) :
.
)
:
) :
6-12 3 50
5 .
24
.
) :
5% . ,
2
.
) nPA, : nPA,
1 3
.
(
, , )
.
V)
)
1,1g /kg /. nPA
1g/kg /.
)
30-40 /kg /, ,
.
(1)
(2)
(6)
(c)
(9)
(12)
(3)
(8)
(5)
()
- ()
1,1-1,2mg*
1,1-1,3 mg
10mg
75-90mg
1mg
2,4g
14-16mg
30g
5mg
700-900g ()
400-800IU
90-120g ()
800-1000mg ()
2000mg
(,
)
2000-2300mg (, .. 5-6g )
50-70mmol ()
8mg () 15mg ()
( EPO)
10-15mg () 8-12mg ()
(
)
55g (
)
* ( )
(per os IV).
V)
.
3 .
.
.
.
.
( ) ,
.
10
> 20 /kg /, 0,8gr/kg ,
.
3-6 .
15.
(, , ,
,
).
.
,
6-12 (
).
20-22mmol/L.
<20mmol/L
(
40mmol/L) .
4)
.
,
.
,
.
4 (GFR<30ml/min/1,73m2)
.
.
.
(
>600cc/min > 5ml, ).
()
.
.
.
V)
11
/
.
.
( ) ,
.
(
: >4 ).
(rope ladder technique)
.
V)
( triplex
transoning, crit-line III,).
VI)
,
().
.
, .
VII)
,
.
.
.
VIII)
IX)
12
.
,
.
.
.
.
( , ),
.
.
( )
.
.
,
.
13
2
2 .
2 4
.
,
.
.
.
.
5)
)
, ,
,
,
(unfractionated heparine).
,
,
(
)
.
V)
)
( HI),
, (refludan)
14
(unfractionated)
,
.
15
, ,
6)
, ,
/
aureus
:
) screening (
aureus )
) aureus,
) , ,
) :
-
- ()
-
.
16
2
4 (
),
2-4 (
)
,
2
(4 ).
36
, , 2
,
,
.
.
(MRSA)
MRSA. , gram (
aeruginosa) 3 4
.
(.. , .)
mantoux, mantoux
, , ,
, , ,
mantoux.
mantoux
.
.
, C HIV
17
.
3-6
C. 6
ELISA (RIBA).
HIV
.
screening HIV .
,
, :
18
( )
C
,
C
(inoculation)
/
(
).
AZT,
, ,
HIV.
.
0,1,6 0,1,2 12 .
(10mIU/ml).
anti-HBs 1, 2
6-12 .
(10mIU/ml).
6.
19
anti-HBs
<10mIU/ml.
.
-
C
. 5
/
.
7)
)
)
(
<100CFU/ml
<0,25 EU/ml).
(-) .
(Association for Advanced
Medical Instrumentation) 2
AAMI
<100
<0.1
200
<0.000001
(CFU/ML)
<2
<0.25
<0.03
<0.03
(IU/ML)
(mg/l)
0.0100
0.0100
0.0060
0.0060
0.0050
0.0050
0.1000
0.1000
0.0004
0.0004
0.0010
0.0010
2(0.02mmol/l)
2(0.05mmol/l)
0.1000
0.0140
0.1000
0.0140
AAMI
20
0.1000
0.1000
0.0200
0.2000
0.5000
0.0200
0.2000
0.5000
0.0050
0.0050
4(0.16mmol/l)
2(0.08mmol/l)
0.0002
0.0010
2.0000
8(0.2mmol/l)
0.0900
2.0000
2(0.08mmol/l)
0.0900
0.0050
0.0050
70(3.0mmol/l)
100
0.0020
50(2.2mmol/l)
100
0.0020
0.1000
0.1000
.
.
.
( )
.
.
()
.
/./
21
12
.
. (, , )
(, )
.
1
.
22
( )
( , PH, , )
.
.
.
on-line .
/
.
.
8)
Biofilm .
.
.
.
(.. 2m-).
.
23
24